Bringing the fundamentals into focus…
Back to Regencell Bioscience Holdings Limited
How Regencell Bioscience Holdings Limited stacks up
RGC · against 329 other Healthcare companies of similar size
Overall
11/ 100
Near the bottom of its peers.
Ranked #326 of 330 · scores higher than 1% of peers
Bars: peers in each 10-point band of the overall score7 peers with an overall score of 10–19, including RGC · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around RGC| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 2 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 4 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 5 | 2.29T KRW (≈$1.6B) | 88 | 83 | 90 | 96 | 0 / 2 | |
| 323 | 3.4B USD | 17 | 8 | — | 20 | 2 / 2 | |
| 324 | 34.9B CNY (≈$4.9B) | 16 | 0 | 0 | 22 | 1 / 2 | |
| 325 | 12.1B CNY (≈$1.7B) | 15 | 0 | 25 | 26 | 2 / 2 | |
| 326 | 17.6B CNY (≈$2.5B) | 11 | 0 | 5 | 32 | 2 / 2 | |
| 326 | 3.0B USD | 11 | 0 | — | 10 | 2 / 2 | |
| 328 | 14.2B CNY (≈$2.0B) | 10 | 0 | 12 | 23 | 2 / 2 | |
| 329 | 1.6B USD | 7 | 8 | 0 | 18 | 2 / 2 | |
| 330 | 2.4B USD | 6 | 8 | — | 8 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score